LYRA ETK is a French medtech company specialized in dental restoration. It integrates traditional implantology and new digital technologies to offer functional and aesthetic restoration solutions. LYRA ETK offers simple, safe and accessible digital dental protocols for the benefit of dentists, laboratories and patients. LYRA ETK is based at the heart of a state-of-the-art industrial site, the number 1 in France for micromechanics and screw-cutting, and controls all the manufacturing stages of its products. We are backed by France's leading dental supplies and equipment distribution group.
ETK was created in 1992 by an eminent dental surgeon and one of the first implantologists trained by Branemark: Dr Guy Huré, who wanted to offer a more accessible alternative to the major brands of implants, with the same guarantees of reliability. As one of the first user of the ETK implants, he undertook numerous studies, in particular with the histology laboratory in Angers, to scrupulously validate their performance.
The Stemmer family group has left its mark on the European dental distribution landscape with its values, impressed by accessibility and passion for what was Armand Stemmer's first profession: dentistry. Today, LYRA ETK is a key player in digital dentistry in implantology, orthodontics and prosthetics.
Creation of Euroteknika (ETK) by Dr Guy HURE in Paris.
Takeover of Euroteknika (ETK) by the STEMMER group.
Integration of production at the 1er French industrial site dedicated to micromechanics, in Sallanches, France (Vallée de l'Arve).
First digital applications: creation of the CAD CAM production centre and launch of guided surgery.
Launch of the Lyramill cabinet maker and creation of the LYRA company.
LYRA and ETK join forces to strengthen their digital product and service offering under the LYRA ETK banner.
Launch of iPhysio, a revolutionary new patented implantology protocol.
Launch of the iBone implant range.
Launch of the Origin implant range.
iPhysio wins the ADF (French Dental Association) innovation award and becomes the gold standard.
Launch of the Dental App and an AI service.
Launch of Digilab, digital flow management software for the laboratory.
The aim of LYRA ETK's innovations is to offer new treatments and protocols to provide better care for your patients, and to meet their expectations in terms of aesthetics, speed, functionality, and comfort. Their performance is validated and reproducible thanks to very precise codified protocols based on science.
Proximity is in the DNA of LYRA ETK. We cultivate a close relationship with the dentists and laboratories who have contributed to building our expertise and our understanding of the constraints faced by practices and laboratories. We are committed to helping dental practitioners and dental technicians develop their business.
Our products are accompanied by protocols guaranteeing the predictability and reproducibility of results. These protocols are codified to provide maximum guidance for the care team.
The LYRA ETK team is agile and responsive. It draws inspiration from technology watch and your needs to constantly develop its ranges.
We are committed to reducing waste and protecting the environment by redesigning our packaging, treating, or recycling our waste and limiting our energy consumption.
2 sites in France: Paris and Sallanches
LYRA ETK is represented in over 30 countries worldwide, with 25 distributors and 4 subsidiaries in Europe.
ETK pays a great deal of attention to research and development, a major factor in its growth and innovation.
Backed by a team of engineers, our Research and Development department monitors clinical and technological developments and conducts fundamental and applied research to develop innovative, patented systems that push back the limits of our treatments.
The R&D department's objectives are to develop new products and constantly improve existing ranges, their production, and associated protocols.
Working with external, neutral partners, our engineers carry out the studies needed to validate our products: digital simulation, fatigue tests, sealing of connectivity, osseointegration, cytotoxicity, etc.